<strong>2007</strong> <strong>National</strong> <strong>Roadside</strong> <strong>Survey</strong> <strong>of</strong> <strong>Alcohol</strong> <strong>and</strong> <strong>Drug</strong> <strong>Use</strong> <strong>by</strong> <strong>Drivers</strong>: <strong>Drug</strong> ResultsSelection <strong>of</strong> <strong>Drug</strong>s for Screening <strong>and</strong> AnalysisPIRE <strong>and</strong> NHTSA jointly developed an initial list <strong>of</strong> drugs to be detected based on the literature(e.g., Jones, Shinar, & Walsh, 2003; Couper & Logan, 2004) <strong>and</strong> experience with drug-involveddriving research. The drugs were selected because <strong>of</strong> a combination <strong>of</strong> their potential impaireddrivingeffects, their likelihood <strong>of</strong> appearing in drivers, <strong>and</strong> in the case <strong>of</strong> oral fluid, theavailability <strong>of</strong> scientific techniques to analyze oral fluid to detect <strong>and</strong> quantify the drug. NHTSAthen provided this list to experts in the field <strong>of</strong> epidemiology <strong>of</strong> drug use, driving, <strong>and</strong> toxicologyboth in the United States <strong>and</strong> abroad. The experts responded to the list with additions <strong>and</strong>deletions.The list <strong>of</strong> selected drugs is shown in Table 13. The first five categories <strong>of</strong> drugs listed constitutethe <strong>National</strong> Institute on <strong>Drug</strong> Abuse (NIDA)-5, which are prevalent drugs <strong>of</strong> abuse <strong>and</strong> <strong>of</strong>universal interest in the study <strong>of</strong> drug involvement. The NIDA-5 are routine components <strong>of</strong> adrug-screening panel. The other drugs on the list (with the exception <strong>of</strong> barbiturates) appear inthe NHTSA publication titled “<strong>Drug</strong>s <strong>and</strong> Human Performance Fact Sheets” (Couper & Logan,2004) <strong>and</strong> are <strong>of</strong> interest because the expert panel for that effort believed those drugs presentedpotential traffic safety risks. The drugs we tested for represented illegal, prescription, <strong>and</strong> overthe-counterdrugs that (1) have the potential to impair driving performance <strong>and</strong> (2) couldreasonably be expected to appear in the driver population.<strong>Drug</strong> ClassCocaine(Cocaine,benzoylecgonine)Opiates(6-AM, codeine,morphine,hydrocodone,hydromorphone)Amphetamine/Methamphetamine(MDMA, MDA, MDEA,Ephedrine,Psuedoephedrine)Cannabinoids(THC, THC-COO[THCA])Table 13. Selected <strong>Drug</strong>s <strong>and</strong> Minimum Detection Concentrations †Minimum ConcentrationOral Fluid (ng/mL)Minimum ConcentrationBlood (ng/mL)Screen Confirm Screen Confirm20 8 25 1040 10 25 10505050 2020104 2 10 1Self-report ItemCocaine (e.g., crackor coke)HeroinMorphine or Codeine(e.g., Tylenol ® withcodeine)Amphetamine orMethamphetamine(e.g., speed, crank,crystal meth)EcstasyMarijuana (e.g., pot,hash, weed)Phencyclidine 10 10 10 10 PCP (e.g., angeldust)Benzodiazepines(oxazepam,nordiazepam,bromazepam,flurazepam,10 5 20 10Benzodiazepines(e.g., Valium ® ortranquilizers)24
<strong>2007</strong> <strong>National</strong> <strong>Roadside</strong> <strong>Survey</strong> <strong>of</strong> <strong>Alcohol</strong> <strong>and</strong> <strong>Drug</strong> <strong>Use</strong> <strong>by</strong> <strong>Drivers</strong>: <strong>Drug</strong> Results<strong>Drug</strong> Classflunitrazepam,lorazepam,chlordiazepoxide,temazepam, diazepam,clonazepam,alprazolam, triazolam,midazolam,nitrazepam)Barbiturates(Phenobarbital,pentobarb,secobarbital, butalbital)Minimum ConcentrationOral Fluid (ng/mL)Minimum ConcentrationBlood (ng/mL)Screen Confirm Screen Confirm50 50 500 500Self-report ItemBarbiturates (e.g.,phenobarbital)Methadone 50 25 50 10 MethadoneEthyl alcohol .02% .02% .02% .02% <strong>Alcohol</strong>Oxycodone (Percocet ® ) 25 10 25 10Propoxyphene(Darvon ® )10 10 10 10Tramadol (Ultram ® ) 50 25 50 10Carisoprodol (Soma ® ) 100 50 500 500Meperidine (Demerol ® )Sertraline (Zol<strong>of</strong>t®) 50 25 50 10Fluoxetine (Prozac ® ) 50 25 50 10TricyclicAntidepressants(amitryptiline,nortriptyline)25 25 25 10Zolpidem (Ambien ® ) 10 10 10 10Methylphenidate(Ritalin ® )10 10 10 10Dextromethorphan 50 20 50 20Prescription painkillers (e.g.,Percocet®,OxyContin ® ,oxycodone, Demerol ® ,Darvon ® )Antidepressants (e.g.,Prozac ® , Zol<strong>of</strong>t ® )Ambien ® or othersleep aidsADHD medications(e.g., Ritalin ® )Cough medicines(e.g., Robitussin ® ,Vicks 44 ® , etc.)Ketamine 10 10 10 10 Ketamine/Special K† Screening utilizes ELISA micro-plate <strong>and</strong> confirmation utilizes GC/MS or LC/MS/MS technology.We screened using ELISA micro-plate technology. Confirmation was performed using GC/MSor LC/MS/MS technology. Our toxicological laboratory, Immunalysis Corporation, provided allnecessary confirmations.Cocaine, which can be used as a local anesthetic, is <strong>of</strong>ten abused because <strong>of</strong> its stimulatingeffects on the central nervous system (CNS). At low doses, cocaine might actually haveperformance enhancing effects; however, little is known about its effects on human performanceat higher levels <strong>and</strong> in conjunction with alcohol. It is clearly a drug <strong>of</strong> abuse in the United States<strong>and</strong> worthy <strong>of</strong> study in drivers.Opiates are narcotic analgesics used both medicinally <strong>and</strong> as drugs <strong>of</strong> abuse. After an initial rush,opiates act as CNS depressants <strong>and</strong> certainly could have performance-decreasing effects.25